Drugs / Dendritic Cell Tumor Peptide Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05457959 | Dec 2024 → Dec 2029 | diffuse glioma, H3 G34 mutant | Jonsson Comprehensive Cancer Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cell Tumor Peptide Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05457959 ↗ |
| Modality | Vaccine | “peptide-pulsed dendritic cell vaccination” NCT05457959 ↗ |